Prince Pharmaceutical Co., Ltd. (TPEX:6935)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
30.80
+0.20 (0.65%)
Apr 20, 2026, 1:24 PM CST
Market Cap1.12B +36.0%
Revenue (ttm)1.06B +53.1%
Net Income96.32M
EPS2.61
Shares Out36.61M
PE Ratio11.72
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume9,000
Average Volume55,300
Open30.60
Previous Close30.60
Day's Range29.40 - 30.85
52-Week Range20.20 - 35.85
Beta0.71
RSI57.65
Earnings DateMay 12, 2026

About Prince Pharmaceutical

Prince Pharmaceutical Co., Ltd. manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally. The company also offers health food and medicines; vitamin c tablets, vitamin b complex tablets, natto and rhodiola extract capsules, probiotic sachets, and plant extract capsules; and API products comprising felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. Prince ... [Read more]

Sector Healthcare
Founded 1962
Employees 210
Stock Exchange Taipei Exchange
Ticker Symbol 6935
Full Company Profile

Financial Performance

Financial Statements